FDA Inspection 830634 — Batzofin Fertility Services d.b.a. New York Fertility Services

Batzofin Fertility Services d.b.a. New York Fertility Services — FEI 3007196536

The FDA completed an inspection of Batzofin Fertility Services d.b.a. New York Fertility Services on May 10, 2013 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1223021 CFR 1271.50(a)Responsible person to determine, document